发明名称 SUPPRESSION OF TUMOR BY ADMINISTRATION OF PARTRICIN DERIVATIVE
摘要 PROBLEM TO BE SOLVED: To carry out antitumor treatment to leukemia, lymphoma, myeloma, or the like, by administering a definite amount of partricin A and/or B derivative having selective toxicity to tumor cell to an animal, especially human for which antitumor treatment is required. SOLUTION: Partricin A and/or B derivative (preferably N- dimethylaminoacetylpartricin A2-dimethylaminoethylamide and its diascorbic acid salt) having selective toxicity to tumor cell, in a definite amount, preferably about 0.025-3 mg, more preferably about 0.15-1.5 mg/kg weight as daily dose by parenteral administration is administered to an animal, preferably mammal, especially human having tumor cell and/or readily susceptible to tumor and required antitumor treatment.
申请公布号 JP2000169377(A) 申请公布日期 2000.06.20
申请号 JP19980348322 申请日期 1998.12.08
申请人 KUATEKKUSU NV 发明人 BRUZZESE TIBERIO
分类号 C07H17/08;A61K31/00;A61K31/28;A61K31/282;A61K31/445;A61K31/4465;A61K31/4523;A61K31/4545;A61K31/505;A61K31/519;A61K31/529;A61K31/70;A61K31/7028;A61K31/7034;A61K31/704;A61K31/7042;A61K31/7048;A61P35/00;A61P35/02;(IPC1-7):A61K31/704;A61K31/454 主分类号 C07H17/08
代理机构 代理人
主权项
地址